Perineural space invasion in cervical cancer (FIGO IB1-IIB) accompanied by high-risk factors for recurrence

J Cancer Res Ther. 2014 Oct-Dec;10(4):957-61. doi: 10.4103/0973-1482.138126.

Abstract

Background: Perineural space invasion (PSI) represents a poor prognostic factor in various carcinomas. Studies on PSI in cervical cancer patients are scarce and report discrepant results regarding its incidence and prognostic value.

Aims: The aim of the following study was to evaluate the occurrence rate and prognostic significance of parametrial PSI in patients cervical cancer (FIGO IB1-IIB), accompanied by high-risk factors for recurrence.

Materials and methods: We reviewed clinical records and pathology slides of patients with cervical cancer after radical hysterectomy. Only patients with at least one of following factors: Depth of invasion of ≥15 mm, parametrial and lymph node involvement, were enrolled in the study.

Results: A total of 50 patients fulfilled the above mentioned criteria. Parametrial PSI was found in 9 (18%) patients (Group I), whereas the remaining 41 (82%) subjects constituted group II. The presence of PSI proved to correlate with the depth of invasion of ≥15 mm (P=0.006) and tumor size of ≥40 mm (P=0.01), as well as a more advanced stage of the disease (P=0.04). No statistically significant differences in recurrence-free survival rate between the two groups were observed.

Conclusions: We were able to correlate parametrial PSI with the depth of invasion, tumor size and more advanced stage of the disease in early-stage cervical cancer with high-risk of recurrence. No association with a worse prognosis was observed.

MeSH terms

  • Aged
  • Carcinoma / pathology*
  • Carcinoma / therapy*
  • Disease-Free Survival
  • Female
  • Humans
  • Hysterectomy
  • Kaplan-Meier Estimate
  • Middle Aged
  • Neoplasm Recurrence, Local / pathology
  • Neoplasm Staging
  • Peripheral Nerves / pathology*
  • Prognosis
  • Risk Factors
  • Treatment Outcome
  • Uterine Cervical Neoplasms / pathology*
  • Uterine Cervical Neoplasms / therapy*